Background
Methods
Subjects
Characteristics | Control | Lupus nephropathy |
---|---|---|
n | 232 | 225 |
Mean age (years) mean ± SD | 34.9 ± 9.8 | 35.2 ± 10.1 |
Sex ratio (Female: Male) | 85/147 | 81/144 |
24-hour proteinuria (mg) | - | > 500 |
persistent hematuria | - | yes |
s-Cr(mg/dL) | - | > 1.3 |
Genotyping of the SNPs of the ACE gene and the eNOSgene
SNP | Location | Primer sequence | Enzyme | Amplification length | The length of digested fragments |
---|---|---|---|---|---|
F-gccatgtcacatgtattatagga |
EcoRV
| 133 bp | 24 bp + 109 bp | ||
ACE A-5466C
| 5'UTR | ||||
R-cgtctttggaaacttgtctgc | |||||
F-atagtgtatatagggcttggtac |
PstI
| 114 bp | 90 bp + 24 bp | ||
ACE T-3892C
| 5'UTR | ||||
R-agaagatatttgcaaagtatgtactg | |||||
F-tgtcactccggaggcgggaggct |
XbaI
| 168 bp | 145 bp + 23 bp | ||
ACE A-240T
| 5'UTR | ||||
R-gagaaagggcctcctctctct | |||||
F-agtgcacacgggtcacgatg |
BsmBI
| 287 bp | 95 bp +192 bp | ||
ACE C1237T
| exon8 | ||||
R-caccaagtagccaaagggcag | |||||
F-cacaccctgaagtacggcac |
HaeII
| 131 bp | 109 bp + 22 bp | ||
ACE G2215A
| exon14 | ||||
R-tcctccagctcctgggcag | |||||
F-ctgacgaatgtgatggccgc |
BstUI
| 122 bp | 103 bp + 19 bp | ||
ACE A2350G
| exon16 | ||||
R-ttgatgagttccacgtatttcg | |||||
F-tggagatgatggtgtacccca |
MspI
| 180 bp | 94 bp +46 bp +42 bp | ||
eNOS T-786C
| 5'UTR | ||||
R-gcctccacccccaccctgtc | |||||
F-aaggcaggagacagtggatgga
|
Ban II
| 248 bp | 163 bp + 85 bp | ||
eNOS G894T
| Exon7 | ||||
R- cccagtcaatccctttggtgctca |
Statistical analysis
Results
Genotype distribution of the ACEgene between patients with lupus nephropathy and controls
SNP | Genotype | Control N = 232 (%) | Lupus nephropathy N = 225 (%) |
p
| OR (95%CI) |
---|---|---|---|---|---|
AA | 79(34.05) | 108(48.44) |
0.002*
|
0.559(0.384-0.816)
| |
AC | 107(46.12) | 91(40.44) | 0.221 | 1.260(0.870-1.826) | |
ACEA-5466C
| CC | 46(19.83) | 26(11.56) |
0.015*
|
1.893(1.124-3.186)
|
A allele | 265(57.11%) | 307(68.22%) |
0.001*
|
0.620(0.473-0.813)
| |
C allele | 199(42.89%) | 143(31.78%) |
0.001*
|
1.612(1.230-2.113)
| |
TT | 50(21.55) | 43(19.11) | 0.517 | 1.163(0.737-1.835) | |
TC | 112(48.28) | 99(44.00) | 0.359 | 1.188(0.822-1.717) | |
ACE T-3892C
| CC | 70(30.17) | 83(36.89) | 0.128 | 0.739(0.501-1.092) |
T allele | 212(45.69%) | 185(41.11%) | 0.163 | 1.205(0.927-1.566) | |
C allele | 252(54.31%) | 265(58.89%) | 0.163 | 0.830(0.639-1.078) | |
AA | 93(40.09) | 79(35.11) | 0.272 | 1.236(0.846-1.807) | |
AT | 102(43.97) | 111(47.84) | 0.250 | 0.806(0.558-1.164) | |
ACEA-240T
| TT | 37(15.95) | 35(15.56) | 0.908 | 1.030(0.623-1.704) |
A allele | 273 (62.07%) | 269(59.78%) | 0.772 | 0.962(0.739-1.252) | |
T allele | 191(37.93%) | 181(40.22%) | 0.772 | 1.040(0.799-1.354) | |
ACE C1237T
| CC | 24(10.34) | 19(8.44) | 0.487 | 1.251(0.665-2.353) |
CT | 89(38.36) | 96(42.67) | 0.349 | 0.836(0.575-1.216) | |
TT | 119(51.29) | 110(48.89) | 0.607 | 1.101(0.763-1.589) | |
C allele | 137(29.53%) | 134(29.78%) | 0.934 | 0.988(0.744-1.312) | |
T allele | 327(70.47%) | 316(70.22%) | 0.934 | 1.012(0.762-1.344) | |
GG | 98(42.24) | 87(38.67) | 0.436 | 1.160(0.798-1.686) | |
AG | 102(43.97) | 102(45.33) | 0.769 | 0.946(0.654-1.368) | |
ACEG2215A
| AA | 32(13.79) | 36(16.00) | 0.507 | 0.840(0.501-1.407) |
G allele | 298(64.22%) | 276(61.33%) | 0.366 | 1.132(0.865-1.480) | |
A allele | 166(35.78%) | 174(38.67%) | 0.366 | 0.884(0.676-1.156) | |
AA | 138(59.48) | 163(72.44) |
0.003*
|
0.558(0.377-0.827)
| |
AG | 75(32.33) | 53(23.56) |
0.037*
|
1.550(1.026-2.343)
| |
ACEA2350G
| GG | 19 (8.19) | 9(4.00) | 0.062 | 2.141(0.947-4.838) |
A allele | 351(75.65%) | 379(84.22%) |
0.001*
|
0.582(0.418-0.810)
| |
G allele | 113(24.35%) | 71(15.78%) |
0.001*
|
1.719(1.235-2.391)
| |
CC | 9(3.88) | 11(4.89) | 0.598 | 0.785(0.319-1.933) | |
TC | 59(25.43) | 57(25.33) | 0.981 | 1.005(0.660-1.532) | |
eNOS T-786C
| TT | 164(70.69) | 157(69.78) | 0.831 | 1.045(0.699-1.560) |
T allele | 387(83.41%) | 371(82.44%) | 0.700 | 1.070(0.758-1.511) | |
C allele | 77(16.59%) | 79(17.56%) | 0.700 | 0.934(0.662-1.319) | |
eNOS G894T
| GG | 179(77.16) | 195(86.67) |
0.008*
|
0.520(0.318-0.850)
|
GT | 46(19.83) | 27(12.00) |
0.022*
|
1.814(1.083-3.037)
| |
TT | 7(3.02) | 3(1.33) | 0.215 | 2.312(0.593-9.019) | |
G allele | 404(87.07%) | 417(92.67%) |
0.005*
|
0.533(0.341-0.833)
| |
T allele | 60(12.93%) | 33(7.33%) |
0.005*
|
1.877(1.201-2.932)
|
Haplotype | Control 2N = 464 (%) | Lupus nephropathy 2N = 450 (%) |
p
| OR (95%CI) |
---|---|---|---|---|
ACATGA | 52(11.21) | 49(10.89) | 0.878 | 1.033(0.683-1.562) |
CCATAA | 23(4.96) | 30(6.67) | 0.269 | 0.730(0.417-1.277) |
ACATAA | 21(4.53) | 31(6.89) | 0.123 | 0.641(0.362-1.133) |
CCATGA | 22(4.74) | 25(5.56) | 0.577 | 0.846(0.470-1.524) |
ATTCGA | 12(2.59) | 23(5.11) |
0.047*
|
0.493(0.242-1.003)
|
ACTTGA | 22(4.74) | 20(4.44) | 0.830 | 1.070(0.576-1.989) |
ATATGA | 25(5.39) | 13(2.89) | 0.058 | 1.914(0.967-3.791) |
CCTTAA | 32(6.90) | 23(5.11) | 0.256 | 1.375(0.792-2.389) |
ATTTAA | 13(2.80) | 21(4.67) | 0.136 | 0.589(0.291-1.191) |
ACACGA | 13(2.80) | 17(3.78) | 0.408 | 0.734(0.352-1.530) |
ATATAA | 6(1.29) | 14(3.11) | 0.060 | 0.408(0.155-1.071) |
CCATGG | 16(3.45) | 11(2.44) | 0.370 | 1.425(0.654-3.106) |
ATACGA | 11(2.37) | 16(3.56) | 0.290 | 0.659(0.302-1.435) |
ACTTAA | 20(4.31) | 6(1.33) |
0.007*
|
3.333(1.326-8.379)
|
ATTTGA | 16(3.45) | 10(2.22) | 0.265 | 1.571(0.705-3.501) |
CCTTAG | 6(1.29) | 14(3.11) | 0.060 | 0.408(0.155-1.071) |
CTTCGA | 1(0.22) | 13(2.89) |
0.001*
|
0.073(0.009-0.557)
|
ACACGG | 11(2.37) | 3(0.67) |
0.036*
|
3.618(1.003-13.056)
|
ACTCGA | 5(1.08) | 9(2.00) | 0.256 | 0.534(0.177-1.605) |
ACATGG | 11(2.37) | 3(0.67) |
0.036*
|
3.618(1.003-13.056)
|
CCACGA | 10(2.16) | 4(0.89) | 0.119 | 2.456(0.765-7.888) |
CCATAG | 6(1.29) | 6(1.33) | 0.957 | 0.969(0.310-3.028) |
ACACAA | 3(0.65) | 9(2.00) | 0.072 | 0.319(0.086-1.186) |
ACTCAA | 7(1.51) | 10(2.22) | 0.425 | 0.674(0.254-1.786) |